Halfords Group (LSE: HFD) has told investors its full-year profit before tax is set to land near the top of City expectations, sending shares 11% higher in early Wednesday trading. The UK’s
More
Microsoft Corporation (NASDAQ: MSFT) enters its fiscal third quarter 2026 earnings release on Wednesday carrying more narrative complexity than almost any other technology company reporting this season, with the restructured OpenAI partnership
More
Meta Platforms Inc. (NASDAQ: META) delivers its Q1 2026 earnings on Wednesday April 29 against a backdrop that could fairly be described as schizophrenic: the company has simultaneously announced 8,000 layoffs equivalent
More
London never runs short of new places to eat. King’s Cross, Shoreditch, and newer riverside zones all attract fresh attention. Yet Soho still holds a special place in the city’s dinner habits.
More
Alphabet Inc. (NASDAQ: GOOGL / GOOG) heads into its Q1 2026 earnings announcement on April 29 carrying what the Armchair Trader has described as the strongest analyst conviction of any mega-cap technology
More
Intel delivered one of the most dramatic single-session stock performances seen in the American technology sector for nearly four decades on Friday, surging more than 23 percent after first-quarter earnings massively exceeded
More
X-Energy, the Rockville, Maryland-based developer of small modular nuclear reactors and advanced nuclear fuel, began trading on the Nasdaq on Friday under the ticker symbol XE, opening at $30.11 against an IPO
More
ServiceNow (NYSE: NOW) shares fell nearly 18 percent on Thursday in one of the most counterintuitive earnings reactions of the season, with the enterprise software platform reporting first-quarter results that beat analyst
More
Tesla delivered a mixed set of first-quarter results on Wednesday evening, posting revenues of $22.38 billion and earnings per share of $0.41, beating analyst expectations on both headline measures but pulling back
More
AstraZeneca plc (LON: AZN) fell 1.3 percent and GSK plc (LON: GSK) dropped 1.5 percent on Tuesday April 21, making the pharmaceutical sector the weakest performer in the FTSE 100 as investors
More